Literature DB >> 17994284

Depression in adults with Fabry disease: a common and under-diagnosed problem.

A L Cole1, P J Lee, D A Hughes, P B Deegan, S Waldek, R H Lachmann.   

Abstract

BACKGROUND: Anderson-Fabry disease (AFD), an X-linked lysosomal storage disorder, leads to multi-organ dysfunction and premature mortality. Depression in adults with AFD has been reported, but no large study has been done. We have examined the adult Fabry population in the United Kingdom to describe the prevalence, associated factors and frequency of diagnosis of depression.
METHODS: Postal questionnaires were sent from four adult clinics to 296 AFD patients. A response rate of 62% (n = 184; 74 male, 110 female) formed the data set. Questionnaires collected demographic and Fabry-specific information. Depression status was assessed using the Centre for Epidemiological Studies depression scale (CES-D).
RESULTS: Responders were aged between 18 and 76 years (mean 44). The prevalence of depression was 46%, of which 28% were consistent with 'severe clinical depression'. Unlike the normal population, males with AFD report a higher prevalence of severe depression than females (36% males; 22% females). Interference of AFD symptoms with individuals' lives (particularly acroparaesthesiae or anhidrosis) showed the largest odds of association with depression. Relationship and financial status proved strong predictors of depression: 88% of those with mild-moderate depression and 72% with severe depression were undiagnosed.
CONCLUSION: Depression is common and under-diagnosed in AFD. Proper assessment of and treatment for depression could improve the quality of life of these patients.

Entities:  

Mesh:

Year:  2007        PMID: 17994284     DOI: 10.1007/s10545-007-0708-6

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  26 in total

1.  Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females.

Authors:  K D MacDermot; A Holmes; A H Miners
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

2.  Angiokeratoma corporis diffusum. A clinical study of eight affected families.

Authors:  D WISE; H J WALLACE; E H JELLINEK
Journal:  Q J Med       Date:  1962-04

3.  Depression: are we ignoring an important comorbidity in heart failure?

Authors:  Christopher M O'Connor; Karen E Joynt
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

4.  Psychosis in Fabry disease and treatment with phenoxybenzamine.

Authors:  E H Liston; M D Levine; M Philippart
Journal:  Arch Gen Psychiatry       Date:  1973-09

5.  Long-term risk for depressive symptoms after a medical diagnosis.

Authors:  Daniel Polsky; Jalpa A Doshi; Steven Marcus; David Oslin; Aileen Rothbard; Niku Thomas; Christy L Thompson
Journal:  Arch Intern Med       Date:  2005-06-13

6.  Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D).

Authors:  D Hann; K Winter; P Jacobsen
Journal:  J Psychosom Res       Date:  1999-05       Impact factor: 3.006

7.  Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in The Netherlands.

Authors:  A T Beekman; D J Deeg; J Van Limbeek; A W Braam; M Z De Vries; W Van Tilburg
Journal:  Psychol Med       Date:  1997-01       Impact factor: 7.723

8.  Direct and indirect effects of chronic physical conditions on depression: a preliminary investigation.

Authors:  R Vilhjalmsson
Journal:  Soc Sci Med       Date:  1998-09       Impact factor: 4.634

9.  The outcome of depressive disorders in neurology patients: a prospective cohort study.

Authors:  A J Carson; K Postma; J Stone; C Warlow; M Sharpe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

10.  Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.

Authors:  A Mehta; R Ricci; U Widmer; F Dehout; A Garcia de Lorenzo; C Kampmann; A Linhart; G Sunder-Plassmann; M Ries; M Beck
Journal:  Eur J Clin Invest       Date:  2004-03       Impact factor: 4.686

View more
  41 in total

Review 1.  Fabry disease: a rare cause of neuropathic pain.

Authors:  Marieke Biegstraaten; Gabor E Linthorst; Ivo N van Schaik; Carla E M Hollak
Journal:  Curr Pain Headache Rep       Date:  2013-10

Review 2.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

3.  Fabry disease: multidisciplinary evaluation after 10 years of treatment with agalsidase Beta.

Authors:  Politei Juan; Amartino Hernan; Schenone Andrea Beatriz; Cabrera Gustavo; Michref Antonio; Tanus Eduardo; Dominguez Raul; Larralde Margarita; Blanco Mariana; Gaggioli Daniela; Szlago Marina
Journal:  JIMD Rep       Date:  2014-05-22

4.  Stochastic Curtailment of Questionnaires for Three-Level Classification: Shortening the CES-D for Assessing Low, Moderate, and High Risk of Depression.

Authors:  Niels Smits; Matthew D Finkelman; Henk Kelderman
Journal:  Appl Psychol Meas       Date:  2015-06-29

5.  Cognitive Impairments and Subjective Cognitive Complaints in Fabry Disease: A Nationwide Study and Review of the Literature.

Authors:  Josefine Loeb; Ulla Feldt-Rasmussen; Christoffer Valdorff Madsen; Asmus Vogel
Journal:  JIMD Rep       Date:  2018-04-14

6.  Effect of reduced agalsidase Beta dosage in fabry patients: the Australian experience.

Authors:  Joanna Ghali; Kathy Nicholls; Charles Denaro; David Sillence; Ian Chapman; Jack Goldblatt; Mark Thomas; Janice Fletcher
Journal:  JIMD Rep       Date:  2011-09-15

7.  Fabry disease in latin america: data from the fabry registry.

Authors:  J Villalobos; J M Politei; A M Martins; G Cabrera; H Amartino; R Lemay; S Ospina; S Suarez Ordoñez; C Varas
Journal:  JIMD Rep       Date:  2012-07-06

8.  Cognitive function in adults aging with fabry disease: a case-control feasibility study using telephone-based assessments.

Authors:  Virginia G Wadley; Leslie A McClure; David G Warnock; Caroline L Lassen-Greene; Robert J Hopkin; Dawn A Laney; Virginia M Clarke; Manjula Kurella Tamura; George Howard; Katherine Sims
Journal:  JIMD Rep       Date:  2015-01-08

9.  Social-adaptive and psychological functioning of patients affected by Fabry disease.

Authors:  Dawn Alyssia Laney; Daniel J Gruskin; Paul M Fernhoff; Joseph F Cubells; Opal Y Ousley; Heather Hipp; Ami J Mehta
Journal:  J Inherit Metab Dis       Date:  2010-01-20       Impact factor: 4.982

Review 10.  Fabry disease: recent advances in pathology, diagnosis, treatment and monitoring.

Authors:  Björn Hoffmann
Journal:  Orphanet J Rare Dis       Date:  2009-10-11       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.